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Abstract
Background: Individuals with chronic lung disease are at increased risk of adverse health effects
from airborne particulate matter. Characterization of underlying pollutant-phenotype interactions
may require comprehensive strategies. Here, a toxicogenomic approach was used to investigate
how inflammation modifies the pulmonary response to urban particulate matter.
Results: Transgenic mice with constitutive pulmonary overexpression of tumour necrosis factor
(TNF)-α under the control of the surfactant protein C promoter and wildtype littermates (C57BL/
6 background) were exposed by inhalation for 4 h to particulate matter (0 or 42 mg/m3 EHC-6802)
and euthanized 0 or 24 h post-exposure. The low alveolar dose of particles (16 μg) did not provoke
an inflammatory response in the lungs of wildtype mice, nor exacerbate the chronic inflammation
in TNF animals. Real-time PCR confirmed particle-dependent increases of CYP1A1 (30–100%),
endothelin-1 (20–40%), and metallothionein-II (20–40%) mRNA in wildtype and TNF mice (p <
0.05), validating delivery of a biologically-effective dose. Despite detection of striking genotype-
related differences, including activation of immune and inflammatory pathways consistent with the
TNF-induced pathology, and time-related effects attributable to stress from nose-only exposure,
microarray analysis failed to identify effects of the inhaled particles. Remarkably, the presence of
chronic inflammation did not measurably amplify the transcriptional response to particulate matter.
Conclusion: Our data support the hypothesis that health effects of acute exposure to urban
particles are dominated by activation of specific physiological response cascades rather than
widespread changes in gene expression.
Background
Increased levels of particulate matter (PM) are associated
with respiratory and cardiovascular morbidity and mor-
tality [1-3]. Acute adverse health effects associated with
PM are generally attributed to susceptible subgroups of
the population, including individuals with respiratory
diseases such as chronic obstructive pulmonary disease
(COPD) [4-7]. Exacerbation of existing inflammation and
increased generation of oxidative stress provoking an
acute phase response is one mechanism through which
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PM may cause adverse cardiovascular effects [8]. Inhaled
particles aggravate existing epithelial lesions in the lungs
[9], and impairment of epithelial barrier function can
result in increased translocation of particles to the intersti-
tium [10]. Once in the interstitium, particles are less likely
to be cleared via macrophage phagocytosis, and can cause
interstitial inflammation, induce direct effects on local
cell populations (including macrophages, fibroblasts,
endothelial cells, and neutrophils) and drain to local
lymph nodes [11,12]. Chronic inflammation and oxida-
tive stress may also prime the lungs to respond to particles
with increased production of reactive oxygen species and
inflammatory mediators, exacerbating the existing disease
state [13]. In addition, inflammation and tissue damage
may facilitate direct interaction of PM factors with the pul-
monary endothelium, disturbing vascular function
[14,15] and increasing the risk of acute cardiac events
from plaque instability or reduced myocardial perfusion.
Investigating the interaction of inhaled particles and host
factors governing susceptibility may be critical to under-
standing acute health effects related to PM exposure.
Urban PM is a heterogeneous mixture of organic and inor-
ganic compounds likely to provoke a number of transcrip-
tional and physiological responses in lung tissue [16,17].
We have previously established that mRNA and plasma
levels of the potent vasoconstrictor endothelin (ET)-1 are
increased 25–50% after particle inhalation, a response
that does not require acute lung injury [9,14,18-20].
Increases of plasma ET-1 in this range have high predictive
value for chronic heart failure [21], indicating that the
magnitude of ET-1 change need not be large to have
pathophysiological relevance. Substantiating these ani-
mal studies, elevated plasma ET-1 and increased mean
pulmonary arterial pressure have been measured in chil-
dren exposed to high pollutant levels in Mexico City [22].
While lung injury may not be a prerequisite for pathway
activation, existing injury and inflammation can exacer-
bate or alter the response to inhaled contaminants [9,19].
Interaction of the physiological state of the lungs and the
physicochemical properties of inhaled particles likely
involves multiple pathways, and such complexity is diffi-
cult to investigate by conventional means. Genomic
approaches can contribute to the elucidation of mecha-
nisms by providing context for defined toxicant-related
changes and by identifying novel toxicant-responsive
pathways.
Few studies have examined responses of the pulmonary
transcriptome to urban PM. In an intratracheal instillation
study, lungs of spontaneously hypertensive male rats
exposed to the urban PM preparation EHC-93 exhibited
differential expression of 132 genes with fold-changes of
at least 1.5-fold 2–6 h post-exposure, including genes
involved in oxidative stress, inflammatory response, and
transcription, with fewer genes affected 15–21 h and 24–
40 h post-exposure [23]. As samples were pooled for each
time point it was not possible to assess the statistical sig-
nificance of these effects. A subchronic inhalation expo-
sure study of ApoE/low-density-lipoprotein double
knockout mice exposed to concentrated ambient PM 6 h/
day, 5 d/wk, for 4 mo did not identify any differentially
expressed genes in lung tissue 3–4 d after the final expo-
sure according to statistical analysis of results, although
95 probes were up- or down-regulated by at least 1.5-fold
[24]. A macroarray study with 1176 probes found little
differential expression (9 genes) 3 d after intratracheal
instillation of 10 mg Cardiff PM, and there was poor
agreement with PCR data [25]. To date, no microarray
study has examined immediate or early effects of inhaled
urban PM on pulmonary gene expression. Because of the
rapid onset of cardiovascular effects detected in epidemi-
ologic work [26,27], and the early response of endothelin
system genes in previous targeted gene expression studies
[19,28], this is an important window for investigation.
In the present study we used a toxicogenomic approach to
investigate how chronic inflammation modifies the tran-
scriptional response of the lungs to inhaled urban PM. We
hypothesized that a transcriptome-wide approach would
allow detection of effects not investigated by conventional
means. Furthermore, we hypothesized that chronic
inflammation would amplify the pulmonary transcrip-
tional response to inhaled PM. Transgenic mice with con-
stitutive pulmonary expression of tumour necrosis factor
(TNF)-α under the control of the surfactant protein (SP)-
C promoter develop lung inflammation, characterized by
influx of macrophages, lymphocytes, and neutrophils,
alveolar disruption and airspace enlargement [29,30]. The
resulting lung pathology has been well-characterized
through imaging, histology, and functional analysis [29-
32], and the mice have been used for assessment of effects
of repeated exposure to PM and ozone [33]. Using com-
mercial microarrays we assessed expression of roughly
21,000 transcripts in TNF mice and their wildtype (WT)
littermates exposed by inhalation to urban PM or air. In
this study, the combination of a relatively large sample
size (n = 5/group, 40 arrays total), paired with a standard
reference design controlling for confounding variables,
provided a robust approach to examine transcriptional
profiles associated with PM inhalation in normal and
inflamed lungs. Our objectives were: 1) to evaluate the
utility of microarrays to investigate pollutant-phenotype
interactions at a relevant internal dose of PM; 2) to iden-
tify genes and pathways that respond to inhaled PM; 3) to
investigate how inflammation modifies this response;
and 4) to identify biomarkers of exposure that are robust
to the physiological status of the lungs.Particle and Fibre Toxicology 2009, 6:6 http://www.particleandfibretoxicology.com/content/6/1/6
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Results
Deposition modelling
EHC-6802 particles had a count median diameter (opti-
cal) of 0.58 μm. Analysis of cascade impactor data
revealed a multimodal particle size distribution, with two
respirable modes at 0.85 μm (aerodynamic diameter,
DAE) and 3.0 μm DAE, and a non-respirable mode at 15
μm DAE (Figure 1). Using RDDR2 modelling software, the
pulmonary compartment deposition efficiency was esti-
mated at 11% of inhaled mass for the 0.85 μm DAE particle
mode (20% of aerosol mass), 5% of inhaled mass for the
3.0 μm DAE particle mode (50% of aerosol mass), and
0.1% of inhaled mass for the 15 μm DAE particle mode
(30% of aerosol mass). Given a concentration of 42 mg/
m3 and an inhaled air volume of 8 L over the 4 h exposure
(minute ventilation 34 mL/min), the particle dose deliv-
ered to the pulmonary compartment was estimated at 16
μg (42 μg/L × 8L × {[0.11 × 0.20] + [0.05 × 0.50] + [0.001
× 0.30]}) on 500 cm2 of alveolar septum, or 32 ng/cm2
alveolar surface area. Note that the estimated dose is for
normal mouse lungs. Lung parenchymal surface area
decreases in adult TNF mice due to emphysema, and the
ratio of parenchymal surface area between WT and TNF
mice has been reported to be roughly 2:1 [30]. We have
confirmed a 2:1 ratio of parenchymal surface area in our
animals by stereology on paraffin sections (data not
shown). The dose estimate for TNF mice is therefore 16 μg
on 250 cm2, or 64 ng/cm2.
Lung histology and differential cell counts
Lung histology confirmed that the TNF mice (Figure 2b,
d) had chronic inflammation, enlarged alveolar spaces,
and septal destruction compared to wildtype mice (Figure
2a, c). Differential counts of cells recovered by bronchoal-
veolar lavage confirmed greater numbers of all cell types
in TNF mice relative to their WT littermates (Genotype
main effect, p < 0.001; Figure 2ef). Cellular changes in
TNF mice consisted of a 10-fold increase in cell recovery
in lavage fluid, with a 5-fold increase of macrophages,
pronounced neutrophilia, and the presence of lym-
phocytes and multinucleated giant cells. Inhalation expo-
sure to particles for 4 h did not significantly affect cell
number or composition in either WT or TNF animals,
indicating that changes in gene expression resulting from
PM exposure should reflect changes within the lung tissue
rather than import of signal by influx of inflammatory
cells.
Confirmation of PM effects on key biological pathways
EHC-6802 (but not TiO2) caused a dose-dependent
increase of dioxin response element regulated luciferase
activity in H1L1.1c2 cells (Figure 3a), confirming AhR-
activation by these particles. To verify delivery of a biolog-
ically-effective dose of particles to the lungs, real-time
PCR was used to assess the effect of EHC-6802 on pulmo-
nary expression of two key transcripts induced by PM: the
AhR-regulated gene CYP1A1 [34,35], and endothelin-1
[14,18,19]. Basal CYP1A1 mRNA levels were 70-fold
lower in TNF mice (Figure 3b), in line with known effects
of inflammation on P450 genes [36]. PreproET-1 mRNA
levels in TNF mice were half of those in WT mice (Figure
3b), consistent with the 50% decrease of parenchymal
surface area and thus 50% loss of endothelial capillary
surface area. The deposition of urban particles in the lungs
increased CYP1A1 mRNA (three-way ANOVA, Treatment
main effect, p = 0.05; Figure 3c) and preproET-1 mRNA
(three-way ANOVA, Treatment main effect, p = 0.04; Fig-
ure 3d) in WT and TNF mice. The greater responses in the
lungs of TNF mice (Treatment × Genotype interaction, p >
0.05) is consistent with a higher particulate dose (64 ng/
cm2) relative to WT mice (32 ng/cm2). After accounting
for parenchymal surface area, the relative effect of PM per
unit dose in WT and TNF animals was similar, despite the
wide difference in basal steady-state expression levels.
Microarray processing and quality control
Agilent 22K oligonucleotide arrays were used to assess
pulmonary gene expression in the experimental animals
(1 lung sample/array, n = 5 arrays/treatment, 40 arrays
total). Normalization of arrays resulted in a median ratio
of 1 and an equivalent spread of data for all arrays [see
Additional file 1]. The average background signal was 202
± 35 for the Cy5 (sample) channel and 341 ± 101 for the
Cy3 (reference) channel. Of the 20968 probes, approxi-
mately 61% of sample channel spots were identified as
having a signal above background (spots flagged: 8213 ±
838 for the sample channel; 11649 ± 706 for the reference
channel; 12303 ± 673 for both channels). Hierarchical
clustering of arrays was carried out on lowess normalized
data to identify structure at the sample level [37] (Figure 
Particle size distribution of EHC-6802 Figure 1
Particle size distribution of EHC-6802. The histogram 
represents the mass of particles collected on the individual 
cascade impactor plates. The dotted line represents the par-
ticle size distribution assuming a single mode. The dark curv-
ing line represents the multimodal fit.
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Comparison of lung phenotype of wildtype (WT) and SP-C/TNF-α (TNF) mice Figure 2
Comparison of lung phenotype of wildtype (WT) and SP-C/TNF-α (TNF) mice. (A-D) Mice were euthanized and 
lungs were inflated to 25 cm H2O static pressure by intratracheal instillation of 4% paraformaldehyde in PBS. Sections from 
WT (A, C) and TNF (B, D) mice were stained with hematoxylin and eosin. (A) WT lungs (original magnification 40×). (B) TNF 
lungs exhibited chronic inflammation and air-space enlargement (original magnification 40×). Comparison of WT lungs at 
higher magnification (C) to TNF lungs (D) revealed thickened interstitial areas (original magnification 200×). (E) Effects of PM 
inhalation on lavage cytology. Cells were recovered by bronchoalveolar lavage of mice exposed to EHC-6802 (0, 42 mg/m3) 
and euthanized 0 or 24 h post-exposure. Numbers of all cell types were significantly increased in TNF mice relative to their 
WT littermates (Genotype main effect, p < 0.001). There were no significant effects of particle exposure within each genotype. 
MNGC, multi-nucleated giant cells.Particle and Fibre Toxicology 2009, 6:6 http://www.particleandfibretoxicology.com/content/6/1/6
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4). The main branch of the tree divided the arrays into two
groups determined by factor Genotype. After clustering
according to Genotype, most samples clustered by factor
Time, although the distance between successive clusters
was relatively small. In contrast to the fairly tight cluster-
ing with respect to factors Genotype and Time, there was lit-
tle apparent clustering on factor Treatment PM. As no gene
selection criteria were used to generate this visualization,
the results indicate that Genotype effects are highly repro-
In vitro and in vivo assessment of induction of biologically relevant pathways by EHC-6802 Figure 3
In vitro and in vivo assessment of induction of biologically relevant pathways by EHC-6802. (A) Aryl hydrocarbon 
receptor activation in vitro. H1L1.1c2 cells were exposed to vehicle, benzo(a)pyrene, EHC-6802 particles, and TiO2, and luci-
ferase activity was determined. Values represent the mean ± SEM of triplicate determinations. (B) Relative basal mRNA levels 
of CYP1A1 and preproET-1 in the lungs of unexposed WT and TNF mice as measured by real-time PCR. Results are 
expressed as geometric mean ± SD (n = 4 animals/group). (C) PM effects on CYP1A1 mRNA levels in vivo. SP-C/TNF-α (TNF) 
mice and their wildtype (WT) littermates were exposed to 0 or 42 mg/m3 EHC-6802 and euthanized 0 or 24 h post-exposure. 
Real-time PCR was used to determine expression. Results are expressed as geometric mean ± SD (n = 5 animals/group). 
*Treatment main effect, p = 0.05, one-tailed. (D) PreproET-1 mRNA levels in WT and TNF mice 0 and 24 h after exposure to 
EHC-6802. *Treatment main effect, p = 0.04, one-tailed.
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ducible, and also provide some evidence of effects related
to duration of recovery post-exposure.
MAANOVA
To verify that the substantial differences in pulmonary
gene expression between WT and TNF mice did not violate
the common variance assumption, we tested the underly-
ing empirical distribution of the residuals for Genotype
using the Kolmogorov-Smirnov test. For all but one probe
(20867 of 20868), there was insufficient evidence to con-
clude that the common-variance assumption was vio-
lated. Differential expression according to the factors
Treatment,  Time, and Genotype  was assessed by
MAANOVA, with FDR-adjusted p < 0.05 considered sig-
nificant. A visual representation of fold-change and statis-
tical significance for each pairwise comparison revealed
substantial differential expression attributable to factor
Genotype, some differential expression attributable to fac-
tor Time, and little differential expression attributable to
factor Treatment (Figure 5), consistent with the array clus-
tering. Upper and lower bounds for the number of probes
significantly affected (FDR-adjusted p < 0.05) were
defined according to the intersection and union of probes
identified in all pairwise comparisons involving the factor
(i.e. Treatment, Time, or Genotype) in question (Table 1).
TNF mice had significantly altered expression of 1864–
3331 probes (intersection-union) compared to WT mice.
There was a lesser effect for factor Time, with 21–291
probes found to be significantly different between the two
time-points. Eight probes were differentially expressed in
any Treatment comparison (Treatment × Genotype × Time
interaction, FDR-adjusted p < 0.05), and of these, only
four were deemed present (AK020160, RIKEN cDNA
6720475J19 gene; XM_138945, RIKEN cDNA
4921531P07 gene; XM_149258, zinc finger protein 217;
NM_007657, CD9 antigen). None were common to more
than one pairwise comparison group. Complete lists of
differentially expressed genes are available in the NCBI
Gene Expression Omnibus (Accession # GSE11037; http:/
/www.ncbi.nlm.nih.gov/projects/geo).
Hierarchical clustering of arrays to examine structure at the sample level Figure 4
Hierarchical clustering of arrays to examine structure at the sample level. All 40 arrays were clustered by average 
linkage using block-adjusted data without prior gene selection. The bars at the base of the figure display the factors Genotype 
(WT, white; TNF, black), Time (0 h, white; 24 h, grey), and Treatment (air, white; PM, hatched) for each sample.
Genotype
Time
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Genotype
Time
TreatmentParticle and Fibre Toxicology 2009, 6:6 http://www.particleandfibretoxicology.com/content/6/1/6
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Functional analysis of Genotype effects
To determine the biological significance of genotype-
related differences, functional analysis was performed on
the list of genes common to all genotype comparisons
(1864 genes). The list of enriched terms was dominated
by terms related to immune and inflammatory responses,
consistent with the lung phenotype (Table 2). As
expected, TNF-α was among the most highly differentially
expressed genes in TNF mice compared to WT animals
(18-fold increase), as was the acute phase protein serum
amyloid A3 (31-fold increase), C-type lectin domain fam-
ily 4 member d (19-fold increase), and a number of chem-
okine and immunoglobulin genes. In contrast, genes with
the lowest expression levels compared to WT included the
collagen binding protein procollagen c-terminal protein-
ase enhancer protein 2 (6-fold decrease), CYP1A1 (6-fold
decrease), and genes involved in cytoskeleton organiza-
tion and biogenesis.
Functional analysis of Time effects
Functional analysis of differentially expressed genes
according to factor Time revealed enrichment of apoptosis
and immune/defence/stress response terms (Table 3).
Enriched terms were consistent across treatment within
each genotype (data not shown), indicating that any PM
effects did not substantially alter effects related to dura-
tion of recovery post-exposure. Among the genes with
greatest fold-changes were angiopoeitin-like 4 (4-fold),
the mitogen activated protein kinase Map3k6 (3-fold),
metallothionein-II (2-fold), and other genes known to
respond to stress and circulating glucocorticoids. Genes
with lower expression immediately after exposure com-
pared to 24 h later included lymphotoxin B (3-fold in WT,
no response in TNF animals) and a number of genes
involved in immune processes.
PCR validation of microarray data
To validate microarray results, real-time PCR was per-
formed on selected transcripts identified as differentially
expressed according to factor Time. Expression was com-
pared to naïve (unexposed) animals to facilitate interpre-
tation of Time  effects (Figure 6). Effects identified by
microarray analysis were consistently validated by real-
time PCR. A stress-responsive gene, metallothionein-II
Table 1: Number of differentially expressed probes for all pair-wise analyses as determined by MAANOVA or fold-change cut-off.
Pairwise Comparison Significant probes (# above background)a Probes with > 1.5 FCb
Treatment WT,0 h (Air vs. EHC) 4 (2) 147
TNF, 0 h (Air vs. EHC) 2 (2) 211
WT, 24 h (Air vs. EHC) 1 (0) 147
TNF, 24 h (Air vs. EHC) 1 (0) 117
Time WT, Air (0 vs. 24 h) 279 (277) 440
TNF, Air (0 vs. 24 h) 34 (34) 269
WT, EHC (0 vs. 24 h) 177 (175) 486
TNF, EHC (0 vs. 24 h) 57 (56) 349
Genotype 0 h, Air (WT vs. TNF) 3303 (3208) 2424
24 h, Air (WT vs. TNF) 2332 (2328) 2279
0 h, EHC (WT vs. TNF) 2447 (2438) 2557
24 h, EHC (WT vs. TNF) 2285 (2282) 2232
Summaryc
Treatment Union 8 (4) 572
Intersection 0 (0) 0
Time Union 291 (286) 1055
Intersection 21 (21) 46
Genotype Union 3331 (3238) 3024
Intersection 1864 (1863) 1327
aNumber of statistically significant probes for each comparison after analysis of three-way and two-way interactions and all main effects. Numbers in 
parentheses indicate probes that have been declared present in at least 4 out of 5 arrays in the group showing a significant effect.
bList of all probes with fold-change (FC) > 1.5; no statistical filtering.
cSummary of pair-wise comparisons. Union refers to the number of probes present in any comparison for a given factor. Intersection refers to the 
number of probes commonly affected in all comparisons for a given factor.Particle and Fibre Toxicology 2009, 6:6 http://www.particleandfibretoxicology.com/content/6/1/6
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(A_51_P246317) exhibited higher expression in experi-
mental animals of both genotypes immediately after
exposure to clean air or PM, with expression returning to
naïve levels 24 h later (Time main effect, p < 0.001; Figure
6a). Metallothionein-II levels were lower in TNF animals
compared to WT animals (Genotype  main effect, p =
0.003). In contrast, expression of platelet-derived growth
factor (PDGF)-α (A_51_370090) was decreased modestly
immediately after exposure, but increased 24 h later in
both genotypes (Time main effect, p < 0.001; Figure 6b).
PDGF-α mRNA levels were lower in TNF mice than in WT
animals (Genotype main effect, p < 0.001). Expression of
angiopoeitin-like 4 (A_51_P338443) was lower in both
genotypes 24 h post-exposure (Time  main effect, p <
0.001; Figure 6c). In all cases, the magnitude of fold-
change of transcripts for the 0 vs. 24 h post-exposure com-
parisons corresponded well with fold-changes calculated
using microarray data.
Interestingly, although metallothionein-II was selected
for PCR validation based on the Time effect, with no sig-
nificant PM effect identified by the array analysis, there
was a statistically significant increase in the levels of this
transcript after particle inhalation when measured by PCR
(Treatment main effect, p = 0.03; Figure 6a). In contrast, of
the 4 probes identified by MAANOVA as exhibiting PM-
dependent changes, real-time PCR failed to confirm sig-
nificant differential expression in the three probes for
which primers were available (RIKEN cDNA 4921531P07
gene, zinc finger protein 217, CD9 antigen), suggesting
that these results were false-positives (data not shown).
Volcano plots of array data Figure 5
Volcano plots of array data. Microarray data analysed in MAANOVA by Fs FDR-adjusted p-value for each pair-wise com-
parison (y-axis) is represented relative to fold-change (x-axis) within factors Treatment, Time, and Genotype. Probes are repre-
sented by "x". The horizontal line represents a false discovery rate (FDR)-adjusted p value of 0.05. Vertical lines represent a 
fold-change of 1.5-fold. Note that results displayed here represent post-hoc analysis and do not respect the hierarchy of testing 
conducted.
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Gene set analysis
Gene set analysis of probes selected with relaxed statistical
stringency may detect subtle effects not identified by strin-
gent statistical analysis, and so this approach was used to
search for PM effects. Screening for gene ontology term
enrichment in gene lists of the top 50 genes according to
unadjusted p-value for all pairwise comparisons failed to
identify coherent functional grouping of differentially
expressed genes for factor Treatment [see Additional file 2].
In contrast, functional analysis of Time effects revealed
enrichment of terms such as immune response, apoptosis,
signalling pathways, blood vessel development and lipid
metabolism [see Additional file 3], consistent with the
analysis using all probes with FDR-adjusted P < 0.05
(Table 3), indicating that the lists were sufficiently large
and representative of effects to enable identification of
biological processes.
Fold change (FC)
A fold-change cut-off approach can be used as a non-sta-
tistical method to determine a list of candidate genes, with
the most likely candidates being probes appearing in mul-
tiple lists across the treatment groups. Probe lists gener-
ated by filtering on FC = 1.5 resulted in the selection of
1327–3024 (Genotype), 46–1055 (Time), and 0–572
(Treatment) probes (intersection-union; Table 1). Again,
no probes were common to all air vs. PM comparisons.
However, two probes were increased by at least 1.5-fold
immediately after PM exposure in both WT and TNF mice,
and were therefore chosen as top candidates for PCR vali-
dation: A_51_P279693 (NM_009992; CYP1A1; FC = 1.5
in WT, 1.9 in TNF; previously validated by real-time PCR)
and A_51_P442894 (AK048310; RIKEN cDNA
1700055N04 gene, aldehyde dehydrogenase 3 family,
member B2; Aldh3b2; FC = 1.5 in WT, 1.6 in TNF). While
altered CYP1A1 expression was confirmed (Figure 3c),
Table 2: Functional analysis of probes that differ according to factor Genotype.*
Functional term Number of genes % of total P-value
immune system process 167 9.12% 4.19 × 10-27
antigen processing and presentation 34 1.86% 1.61 × 10-15
cell activation 56 3.06% 4.48 × 10-9
response to wounding 66 3.60% 4.55 × 10-9
leukocyte activation 53 2.89% 6.90 × 10-9
defence response 81 4.42% 3.19 × 10-9
response to external stimulus 87 4.75% 3.48 × 10-8
cytoskeleton organization and biogenesis 87 4.75% 6.72 × 10-8
hemopoietic or lymphoid organ development 54 2.85% 5.14 × 10-7
inflammatory response 47 2.57% 1.28 × 10-6
taxis 29 1.58% 4.19 × 10-6
mast cell activation 9 0.49% 1.45 × 10-5
lysosome organization and biogenesis 9 0.49% 2.83 × 10-5
cell division 44 2.40% 8.12 × 10-5
* DAVID functional annotation analysis http://david.abcc.ncifcrf.gov/home.jsp was carried out using the list of the genes responding according to 
factor Genotype common to all treatment groups (1864 probes; 1831 unique DAVID IDs), with the Agilent Mouse Microarray G4121A probe list 
serving as background. Representative enriched terms selected from the top 50 of 278 gene ontology terms with a modified Fisher's Exact p < 0.05 
are displayed.
Table 3: Functional analysis of probes that differ according to factor Time.*
Functional term Number of genes % of total P-value
response to biotic stimulus 29 10.28% 3.86 × 10-6
defence response 28 9.93% 5.78 × 10-6
immune response 24 8.51% 2.23 × 10-5
apoptosis 19 6.74% 5.59 × 10-4
intracellular signalling cascade 28 9.93% 5.94 × 10-4
lipid catabolism 7 2.48% 0.001
protein amino acid methylation 4 1.42% 0.004
nitrogen compound catabolism 5 1.77% 0.009
response to stress 22 7.80% 0.009
angiogenesis 7 2.48% 0.01
* DAVID functional annotation analysis http://david.abcc.ncifcrf.gov/home.jsp was carried out using the list of all genes responding according to 
factor Time (286 probes; 282 unique DAVID IDs), with the Agilent Mouse Microarray G4121A probe list serving as background. Representative 
terms selected from 50 gene ontology terms with a modified Fisher's Exact p < 0.05 are displayed.Particle and Fibre Toxicology 2009, 6:6 http://www.particleandfibretoxicology.com/content/6/1/6
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real-time PCR analysis indicated that the Treatment effect
on Aldh3b2 mRNA was not significant (data not shown).
One-colour analysis
A reference design was used in the present study for its
simplicity, flexibility, and ease of data analysis for multi-
factorial experiments [38]. It is, however, well-recognized
that a reference design may add variability as a result of
dividing by a potentially uncertain measurement, which
could reduce the power to detect treatment effects or con-
tribute to the generation of spurious results. Focussing on
PM effects, a one-colour analysis was conducted within
each genotype to verify that use of a common reference
did not impede detection of effects. Only three unidenti-
fied proteins in WT mice (NM_025901, AK029835,
AK036646), and one probe in TNF mice (D83146, Mus
musculus mRNA for Six5_ partial cds; FC = 1.25) were dif-
ferentially expressed according to Treatment. None of
these genes were common to both one and two-colour
analyses. The lack of PM effects in the one-colour analysis
is in line with the two-colour analysis and indicates that
removal of the common reference did not improve detec-
tion of statistically significant PM effects.
Power calculations
Because of the lack of measurable PM effect on pulmonary
gene expression, we carried out power simulations on
two-colour data to determine the sample size required to
detect differential gene expression due to Treatment using
array data from the present study. Data generated for all
four analyses (WT, 0 h; WT, 24 h, TNF, 0 h, TNF, 24 h)
were used in the power calculation and averaged (Figure
7). As expected, the power simulations show an inverse
relationship between the number and magnitude of
changes expected and the number of arrays required. The
data indicate that with the small effect size in this study, a
large number of biological replicates would be required
(e.g. at least 20 per group for a fold-change < 1.8).
Discussion
Despite evidence of transcription factor activation in lung
cells after PM exposure [16], few studies have examined
effects of PM on pulmonary gene expression (reviewed in
[17]). We hypothesized that by evaluating differential
gene expression at the global transcript level, a microarray
approach would enable identification of PM-activated
pathways not investigated by conventional approaches. In
the present work, the impact of PM inhalation on tran-
script profiles in healthy mice and in mice with chronic
lung inflammation was assessed immediately and 24 h
post-exposure to detect effects that could be related to the
rapid response indicated by epidemiologic studies
[26,27]. Using real-time PCR, we confirmed positive
effects of PM inhalation on three distinct pathways: 1) up-
regulation of CYP1A1, relevant to the presence of com-
bustion by-products in the inhaled urban PM and activa-
tion of a procarcinogenic pathway; 2) up-regulation of
metallothionein-II, relevant to the presence of toxic met-
als in the inhaled particles and activation of pathways to
protect against metal toxicity and oxidative stress; and 3)
up-regulation of ET-1, relevant to endothelial dysfunction
generated by deposited toxicants and downstream cardio-
vascular effects. The activation of CYP1A1 and metal-
lothionein-II is in line with our previous report relating
chemical composition with the biological potency of par-
ticles [34]. These responses establish delivery of a biolog-
ically-effective internal dose in our study despite the
absence of visible impacts on lung lavage cytology, and
are consistent with previous work showing that pro-
nounced inflammation and acute lung injury are not pre-
requisites for induction of physiologically-relevant
pathways by PM [9,14]. The early time points assessed
reduce the likelihood that interpretation of molecular
data would be confounded by infiltrating inflammatory
cells, which often peak 24–48 h after acute injury.
Remarkably, although microarray analysis identified sig-
nificant differential gene expression attributable to geno-
type and to duration of recovery post-exposure, no
significant PM effects were found. Since array quality was
internally validated by detection of positive effects, the
data indicate that any effects of inhaled particles were
below the threshold of detection.
As the site of gas exchange, the lungs are continuously
exposed to airborne contaminants, and possess innate
defence mechanisms that facilitate clearance of inhaled
particles without provoking excessive inflammation that
could lead to tissue damage. Chronic inflammation can
impair lung defences by increasing the permeability of the
epithelial barrier and slowing mucocilliary clearance,
facilitating passage of inhaled particles into the tissue
[10]. Depletion of anti-oxidant defences, activation of
redox-sensitive transcription factors, and chromatin
remodelling in the inflamed lungs could all alter the tran-
scriptional response to PM [13]. Microarray data con-
firmed that the pulmonary transcriptome of TNF mice was
substantially different from that of WT littermates, with
activation of inflammatory and immune response path-
ways consistent with the lung phenotype [29,30]. Clearly,
differential expression detected in this model reflects
import of message due to changes in cellularity, such as
influx of inflammatory cells, in addition to strict transcrip-
tional activation by TNF-α. Surprisingly, this persistent
inflammatory state did not measurably amplify or alter
the response to inhaled particles. It is unclear whether the
lack of response is due to functional transcription-inde-
pendent defences in TNF animals, or to insufficient sensi-
tivity to detect subtle PM effects by microarray at the
whole lung level. Despite the higher numbers of inflam-
matory cells in the lungs of TNF mice, levels of ρ-tyrosine,Particle and Fibre Toxicology 2009, 6:6 http://www.particleandfibretoxicology.com/content/6/1/6
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PCR validation of Time effects Figure 6
PCR validation of Time effects. Real-time PCR was used to measure expression of select probes chosen from the list of dif-
ferentially expressed genes according to factor Time (FDR adjP < 0.05). Values represent geometric mean ± SD (n = 5 animals/
group). Units are arbitrary. Measurements for naïve animals (n = 4/genotype) are included to facilitate interpretation of effects. 
The microarray data (the ratio of 0 h/24 h expression and the associated FDR-adjusted p-value) are displayed below each graph 
for comparison. A) Metallothionein-II. Time main effect, p < 0.001; Genotype main effect, p = 0.003; Treatment main effect, p = 
0.03. B) Platelet-derived growth factor (PDGF)-α. Time main effect, p < 0.001. Genotype main effect, p < 0.001. C) Angiopoie-
tin-like 4. Time main effect, p < 0.001; Genotype main effect, p < 0.001. Asterisks denote statistical significance (Holm-Sidak, p < 
0.05). * 0 vs. 24 h within Time; ** WT vs. TNF within Genotype; *** Air vs. EHC within Treatment.
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a product of hydroxylation of phenylalanine indicative of
oxidative stress, are not significantly higher compared to
WT littermates, nor increased in either genotype after
repeated exposure to PM and ozone [33]. This suggests
that anti-oxidant defences may still be functional in the
TNF model. After adjusting for the decreased alveolar sur-
face area in TNF mice [30], PM effects on CYP1A1 and ET-
1 were remarkably similar to those observed in WT ani-
mals. These results indicate that the altered expression of
specific genes relevant to adverse PM effects was robust to
the physiological status of the lungs, despite significant
genotype differences in the basal levels of the transcripts.
The lower basal metallothionein-II mRNA level and
apparent reduced response in TNF mice could reduce
scavenging of toxicologically-relevant metals [34,39].
The data indicate that effects of urban particles on the
lung transcriptome following a single acute exposure by
inhalation are subtle. The EHC-6802 urban particle prep-
aration used in this study is an environmental material
collected in Ottawa, Canada, and is equivalent to the well-
characterized EHC-93 particle preparation [9,18,34]. The
inherent toxicity of EHC-93 particles has been demon-
strated in vivo using intratracheal instillation [39,40], and
inhalation studies have revealed endothelin system acti-
vation in the absence of pronounced inflammatory
changes [14,18,19]. Activation of biologically-relevant
pathways by EHC-6802 is confirmed here by real-time
PCR. Thus, the lack of overt effects detected by microarray
analysis is not likely due to an absence of factors associ-
ated with health effects of particles in this particle prepa-
ration. It remains possible that repeated exposure to
elevated PM levels could induce measurable effects that
were not apparent after the single exposure used here. In
the only other microarray study published in the literature
that has, to our knowledge, examined pulmonary effects
of urban PM in an inhalation model, subchronic exposure
to concentrated ambient PM yielded little evidence of dif-
ferential expression in the whole lung [24]. Note that in
this previous study expression was measured 3–4 days
after the last exposure, and may have missed subsiding
transcriptional events. In the present study, tissues were
recovered immediately and 24 h post-exposure to capture
rapid effects of exposure on gene expression. Statistical
analysis of array data was conducted at varying levels of
stringency such that the absence of detected effects was
unlikely to be due to overly stringent filters. Moreover,
sample and array quality were confirmed by detection of
Time and Genotype effects in line with expected responses.
Compared with the coherence and PCR validation of Time
and  Genotype  effects, the lack of consistent Treatment
effects suggests that the few probes identified as respon-
sive to PM were false-positives, and that the absence of PM
effects was not due to the analytical approach chosen.
Rather, the data suggest that overt, coordinated transcrip-
tional responses, such as would be expected in an inflam-
matory signalling cascade, may not be a major part of the
pulmonary response to inhaled urban particles in this
model.
Internal dose and method of delivery should be consid-
ered when comparing results across studies. Previous
micro- and macroarray studies examining PM effects on
pulmonary gene expression include exposure to saline
suspension of urban PM [23,25], concentrated ambient
particles [24], diesel exhaust particles [41], residual oil fly
ash [42], and ultrafine carbon particles [43]. Studies using
an intratracheal instillation approach employed particle
doses ranging from 1.25–10 mg, delivered as a bolus in
0.5 mL saline [23,25,41,42]. In the present study, the dose
of EHC-6802 within the respiratory compartment was
estimated to be 16 μg (32 ng/cm2 for WT mice and 64 ng/
cm2 for TNF mice). The estimated doses were only 25-fold
(WT mice) or 50-fold (TNF mice) higher than the mod-
elled deposition for a plausible 24 h human exposure sce-
nario (1.3 ng/cm2 [28]), but more importantly, were 100–
1000 times lower than the dose of particles delivered in
the intratracheal instillation studies cited above. Exposure
by inhalation, a lower internal dose of PM, and a slower
dose rate are less likely to provoke an inflammatory
Power simulation using data from the present microarray  study Figure 7
Power simulation using data from the present micro-
array study. The sample size assessment was conducted to 
determine the number of arrays required to detect a given 
fold change difference between exposed and control sam-
ples. Testing for each genotype and time point group 
resulted in four independent assessments for each fold-
change analysis. Results were then averaged, and the number 
of arrays required to detect a given fold-change was plotted 
relative to the minimal detectable fold change. From upper to 
lower, the lines represent simulations in which 50, 100, 500, 
and 1000 genes were set as differentially expressed at the 
fold-change indicated on the x-axis.
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response that could impact transcript levels, and indeed
did not cause a significant influx of inflammatory cells, in
agreement with our previous work in rats [9,14]. Our
inhalation approach should therefore be more sensitive to
changes in parenchymal gene expression and avoid arti-
facts of an overly high internal dose of particles. For ethi-
cal reasons, nose-only exposures should be kept to a
minimum duration, and therefore the dose-rate in our
study was considerably higher than for a 24 h environ-
mental exposure. Nevertheless, the pulmonary deposition
of PM in our inhalation study is directly relevant to the
human experience, once a number of reasonable uncer-
tainty factors are considered. These include possible
decreased potency of EHC-6802 by comparison to fresh
particles, interspecies differences in sensitivity to air pol-
lutants, and the heightened sensitivity within a subset of
the human population, such as the known increased
adverse risk of individuals with COPD, congestive heart
failure, and atherosclerosis [4,5].
While training in nose-only exposure tubes in the days
preceding exposure is aimed at reducing animal stress,
exposure altered the expression of a number of genes in
the lungs, even in animals exposed to filtered air alone.
These changes show some similarity with effects of stress
on other organs, such as the spleen [44], and likely relate
to systemic effects of stress. Since both air and PM-
exposed animals were similarly exposed to the inhalation
system in the present study, such changes do not con-
found interpretation of results. Moreover, within each
genotype, air and particle exposed animals exhibited sim-
ilar Time effects. It is, however, not known to what degree
these changes may impede detection of PM effects in the
subset of genes affected. It is noteworthy that although
metallothionein-II was selected for PCR validation based
on its response to Time, with no significant PM effect
according to array analysis, expression was significantly
increased by PM when measured by the more sensitive
real-time PCR method. The higher levels of metal-
lothionein-II mRNA in PM-exposed animals indicate that,
at least for this gene, effects of exposure to PM and stress
were additive, consistent with work showing that the
mechanism of metallothionein-II induction by restraint
stress is distinct from that by chemical stress [45].
Toxicogenomic analysis in vivo at doses relevant to human
health can be problematic when subtle changes are
expected to arise. The present study shows that inhaled
particles at an internal dose relevant to the human experi-
ence may not cause significant changes in gene expression
detectable at the level of the whole lung using a moderate
number of microarrays. Moreover, small but physiologi-
cally-relevant changes in gene expression, such as activa-
tion of endothelin and xenobiotic-metabolism pathways,
may not be identified by microarray analysis. To detect
statistically significant differential expression of a few
probes from among 21,000 requires relatively large effect
sizes, or a very high number of arrays. Using our data and
taking a conservative approach of 90% confidence, we cal-
culated that 60–70 arrays would be required to detect 1.5-
fold PM effects in animals of a given genotype, assuming
100 differentially expressed genes with FDR-adjusted p <
0.05 (Figure 7). Experiments requiring this number of
arrays may not be practical for many laboratories. Using
fewer arrays and an arbitrary fold cut-off rather than statis-
tical analysis risks inclusion of false-positive results and/
or exclusion of small (< 1.5-fold) but physiologically rel-
evant changes. This type of approach would require exten-
sive RT-PCR on multiple biological replicates to validate
any findings. Alternatively, taking a more traditional
hypothesis-driven approach through selection of probe
subsets diminishes the likelihood of discovering unex-
pected effects. A third possibility, increasing dose to gen-
erate larger effect sizes, may create artifacts such as
overload of clearance pathways. In light of our observa-
tions, there are several approaches that might be consid-
ered for the assessment of pulmonary effects of
contaminant exposure. Since experiments examining
expression in whole lung tissue may be insensitive to focal
responses in target cells, an anatomically-biased or cell-
type specific approach such as laser-capture microdissec-
tion might uncover local impacts of PM inhalation using
fewer arrays. This should be fairly straightforward for the
study of effects in WT animals. However, complex struc-
tural changes and intensive inflammatory infiltration will
complicate analysis in models such as the TNF mice. Sec-
ondly, appropriate pooling of animals may reduce the
impact of biological variability, provided a sufficient
number of arrays hybridized with independently-pooled
RNA are used to permit statistical analysis [46,47]. How-
ever, it is likely that a large number of arrays would still be
required to detect subtle effects. Lastly, a combination of
transcriptome screening and conventional toxicologic
analyses may be appropriate to examine subtle effects of
exposure.
Conclusion
The present study verified increased expression of ET-1,
CYP1A1, and metallothionein-II in both wildtype and
TNF mice exposed by the nose-only inhalation route, con-
sistent with in vitro [34] and in vivo [19,35] analyses, and
in line with our understanding of the impact of PM on car-
diovascular, toxicant metabolism, and metal-responsive
pathways. These effects were robust to the physiological
status of the lungs, and remarkably, did not differ greatly
between genotypes. Although the particles clearly induce
pathways relevant to endothelial dysfunction (ET-1), car-
cinogenicity (CYP1A1), and metal toxicity (metal-
lothionein-II), the exposures did not measurably initiate
inflammation (wildtype) or exacerbate existing inflam-Particle and Fibre Toxicology 2009, 6:6 http://www.particleandfibretoxicology.com/content/6/1/6
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mation (TNF) in the lungs as measured by lavage cytology
and global pulmonary gene expression. Given the
increased susceptibility of individuals with respiratory
disease [4-7], it may be that susceptibility arises as a result
of the interaction of primary effects with host factors, in
addition to any enhancement or alteration of these pri-
mary effects. For example, individuals with existing
endothelial dysfunction and an ineffective compensation
for the vasopressor effect of ET-1 may respond adversely
to a PM-induced increase of circulating ET-1, while
healthy individuals may compensate with release of nitric
oxide and prostacyclin and not exhibit hemodynamic
changes in response to the same relative increase of circu-
lating ET-1. While microarray analysis is a valuable
approach for genome-wide screening of pronounced
effects, such as characterization of transcriptional changes
resulting from TNF over-expression, it may not be partic-
ularly useful for dissecting pathways at the level of the
whole lung after delivery of an environmentally-relevant
internal dose of contaminants. Increased power, site-spe-
cific analysis, or more sensitive animal models may be
required to investigate effects of acute particle exposure on
pulmonary gene expression. In addition, focussed
approaches targeting key endpoints should be considered
to complement genome-wide transcript profiling. Our
data support the hypothesis that adverse health effects of
acute exposure to urban PM may be dominated by physi-
ological response cascades rather than widespread
changes in the expression of genes escaping homeostatic
controls. Nevertheless, transcriptional activation of cer-
tain key pathways, such as endothelin synthesis and xeno-
biotic transformation, may be relevant to these health
effects.
Methods
Animals
SP-C/TNF-α mice were provided by Dr. R. J. Mason
(National Jewish Medical and Research Centre, Denver,
CO, USA) and crossed with C57BL/6 mice (Charles River
Laboratories, St. Constant, QC, Canada). Note that the
SP-C/TNF-α line has been maintained as a heterozygous
line by repeated backcrossing to C57BL/6 mice for over a
decade [29,30,33]. Male transgenic TNF mice and their
WT littermates were genotyped by PCR analysis of
genomic DNA [29]. Animals were exposed as three
cohorts, each approximately 3 months apart, and were
131 ± 5 days old and 28.9 ± 2.8 g (WT: 30.8 ± 2.5 g; TNF:
27.1 ± 1.7) at the time of exposure. Mice were housed in
individual plexiglass cages on wood-chip bedding under
HEPA-filtered air and held to a 12 h dark/light cycle. Food
and water were provided ad libitum. All experimental pro-
tocols were reviewed and approved by the Animal Care
Committee of Health Canada as set forth in the Guide-
lines of the Canadian Council on Animal Care.
PM preparation
The urban particles EHC-6802 consist of a blend of total
suspended PM recovered from filters of the single-pass air-
purification system at the Environmental Health Centre
(Tunney's Pasture, Ottawa, ON, Canada) in 1996, 1998,
2000, and 2002. Particles were mechanically sieved using
a 36 μm mesh filter, and combined in equal proportions.
EHC-6802 was recovered at the same site and in the same
manner as the urban particles EHC-93 [9,18,34], and
chemical characterization of the EHC-6802 material has
confirmed that it is equivalent to the EHC-93 material
(data not shown).
Activation of the aryl hydrocarbon receptor (AhR) by EHC-
6802
The AhR-based luciferase reporter cell line H1L1.1c2
(kindly provided by Dr. M. S. Denison, University of Cal-
ifornia, Davis, CA, USA) was used to assess AhR-activation
by the EHC-6802 particles. H1L1.1c2 cells were exposed
in triplicate to EHC-6802 (1, 10, 100 μg/cm2), 10 nM
benzo(a)pyrene (positive control), and TiO2  (negative
control) in 24-well plates (2 cm2/well) for 4 h, and luci-
ferase activity was measured as previously described [48].
Inhalation exposure
Mice were trained in nose-only exposure tubes over 4 con-
secutive days and then exposed for 4 h to clean air or 42
mg/m3 EHC-6802 by nose-only exposure as described
previously [9,19]. Particle concentration was monitored
during each exposure at the inhalation ports by isokinetic
sampling using 0.2 μm Teflon filters. Filter weight was
divided by the sampling volume to provide a direct esti-
mate of the time-weighted average particle concentration.
Particle counts and size measurements were performed at
the inhalation ports (optical size range of 0.3–10 μm;
Lasair Model 301; Particle Measuring Systems, Boulder,
CO, USA). Aerodynamic size characteristics were deter-
mined by gravimetric cascade impactor analysis of isoki-
netic samples at the inhalation ports (seven-stage Mercer
cascade impactor, 1 L/min, 0.2–5.1 μm effective cut-off
diameter; Intox, Albuquerque, NM, USA) or the chamber
exhaust (seven-stage Mercer cascade impactor, 10 L/min,
0.2 to 9.8 μm effective cut-off diameter; Intox). Multimo-
dal particle size distribution analysis [49] and pulmonary
deposition modelling were performed as previously
described [18]. Deposition model assumptions for mice
were strict nasal breathing, a minute ventilation of 34 mL/
min, an alveolar surface area of 500 cm2, and a tracheo-
bronchial surface area of 3.5 cm2 (default values for the
Regional Deposited Dose Ratio RDDR2 modelling soft-
ware, US EPA).
Collection of biological samples
Mice were anaesthetized by administration of sodium
pentobarbital (60 mg/kg, i.p.) and euthanized by exsan-Particle and Fibre Toxicology 2009, 6:6 http://www.particleandfibretoxicology.com/content/6/1/6
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guination immediately or 24 h after termination of expo-
sure (n = 5 animals of each genotype/treatment/time).
Lungs were washed by bronchoalveolar lavage with warm
saline (37°C) at 30 mL/kg body weight, then flash frozen
in liquid nitrogen and stored at -80°C until isolation of
RNA. Cells recovered by centrifugation (1500 rpm for 10
min at 4°C) were counted in a Coulter Multisizer II (Coul-
ter Canada, Ville St. Laurent, QC, Canada) and differential
cell counts were obtained from cytospin preparations.
Lungs were homogenized in TRIzol and RNA was isolated
according to manufacturer's instructions (Invitrogen Can-
ada Inc., Burlington, ON, Canada), and further purified
using RNeasy Mini Kits (Qiagen Inc., Mississauga, ON,
Canada). RNA was quantified using the RiboGreen RNA
Quantitation Reagent and Kit (Molecular Probes, Eugene,
OR, USA), and quality was confirmed using the Agilent
2100 Bioanalyzer and RNA 6000 NanoLab Chip Kit (Agi-
lent Technologies Canada Inc., Mississauga, ON, Can-
ada). For histology, lungs of unexposed animals (n = 3/
genotype) were inflated in chest at 25 cm H20 static pres-
sure by intratracheal instillation of 4% paraformaldehyde
in phosphate-buffered saline. The lungs were excised,
immersed in fixative, and stored at 4°C. Tissue blocks
were dehydrated in ethanol and embedded in paraffin.
Sections (0.75 μm) were stained with hematoxylin and
eosin.
Real-time reverse transcription-polymerase chain reaction 
(RT-PCR)
Total RNA was reverse transcribed using MuLV reverse
transcriptase and random hexamers according to manu-
facturer's instructions (Applied Biosystems, Mississauga,
ON, Canada). Twenty ng of cDNA was combined with
Quantitect primer assays and real-time PCR supermix
(Qiagen) and run according to the product protocol on
the iCycler thermal cycler (Bio-Rad Laboratories Canada
Ltd., Mississauga, ON, Canada) using 50 μL volumes [50].
Post-run melt curves were routinely inspected to verify
product purity. Expression was calculated relative to refer-
ence genes (β-actin and TATA binding protein) using the
comparative threshold cycle method [51]. Statistical sig-
nificance was assessed by three-way ANOVA with Treat-
ment (Air, EHC), Genotype (WT, TNF), and Time (0, 24 h)
as factors, followed by the Holm-Sidak multiple compar-
ison procedure to elucidate the pattern of significant
effects (α = 0.05; Sigma Stat 3.0, SPSS Inc., Chicago, IL,
USA). PM effects were represented graphically as fold-
change relative to the time and genotype-matched air-
exposed controls.
Microarray hybridization
An unbalanced block factorial design [52] was used for
the factors Treatment (0, 50 mg/m3), Time (0, 24 h), and
Genotype (WT, TNF) and blocked for the nuisance factors
Date of exposure and Day of hybridization [53]. Five biolog-
ical replicates per condition were used for a total of 40
microarrays. Individual 2.5 μg aliquots of RNA from each
sample were amplified and labelled using the Low RNA
Input Fluorescent Linear Amplification Kit (Agilent). Agi-
lent Mouse G4121A Microarrays (containing approxi-
mately 21,000 probes) were hybridized with 5 μg Cy5-
labelled lung RNA and 5 μg Cy3-labelled Universal Mouse
Reference RNA (Stratagene, CA, USA), used as a common
reference on all arrays [38]. Arrays were incubated over-
night at 60°C in Agilent hybridization solution and
washed according to manufacturer's instructions. Arrays
were scanned using a ScanArray Express (Perkin-Elmer
Life Sciences, Woodbridge, ON, Canada), and data were
acquired with ImaGene 5.5 (BioDiscovery, CA, USA).
Statistical analysis of microarray data
The background signal for each array was determined
using the negative control (-)3xSLv1 probe. Spots with
median signal intensities within three standard deviations
of the (-)3xSLv1 probe mean were flagged as absent. Low-
ess normalization [54] was performed using the SAS/STAT
software, Version 8.2 of the SAS System for Windows
(1999–2001 SAS Institute Inc., Cary, NC, USA). Data dis-
plays produced in R, including ratio intensity plots for the
raw and normalized data, comparison boxplots, heat-
maps, dendrograms, and volcano plots, were used for the
assessment of data quality and for visual comparison of
the impact of each factor [55]. The logarithm base 2 rela-
tive intensities were used for subsequent analyses.
The present experiment was designed to evaluate pollut-
ant-phenotype interactions, and as such required the anal-
ysis of multiple factors and interactions among factors. A
factorial design is a suitable statistical framework to max-
imize resources, and permits analysis of multiple factors
with the same precision as if the experiment were
designed to examine one factor, assuming common vari-
ance. The Microarray Analysis of Variance (MAANOVA)
library [56] in R was used to identify differentially
expressed genes. The statistical model included the main
effects Treatment, Time, and Genotype, the three-way inter-
action, and all two-way interactions. The Fs statistic [57],
a shrinkage estimator for the gene-specific variance com-
ponents, was used, and p-values for all statistical tests
were estimated using the permutation method (1000 per-
mutations with residual shuffling). P-values were then
adjusted for multiple comparisons using the false discov-
ery rate (FDR) approach [58]. Group means for the fold-
change calculation were based on the adjusted relative
intensity for each gene after subtracting estimated Date of
exposure and Day of hybridization effects from the normal-
ized ratio. Genes with FDR-adjusted p < 0.05 and present
on at least 4 of 5 arrays in the group showing a significant
effect were considered differentially expressed. Gene
ontology enrichment analysis was performed using theParticle and Fibre Toxicology 2009, 6:6 http://www.particleandfibretoxicology.com/content/6/1/6
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Database for Annotation, Visualization and Integrated
Discovery (DAVID) [59], available at http://
david.abcc.ncifcrf.gov/home.jsp. Agilent GeneSpring GX
was used for filtering on fold-change. Microarray data
were deposited in the NCBI Gene Expression Omnibus
(Accession # GSE11037; http://www.ncbi.nlm.nih.gov/
projects/geo).
Power simulations
Power scenarios were investigated using the
samr.assess.samplesize function in the SAMR library [60]
to determine the sample size (n animals, 1 array/animal)
required to detect 1.25–2.5 fold changes in expression
when comparing control and exposed animals for each
genotype at each time point. The required sample size was
identified through inspection of plots generated from this
application, and corresponded to the value at which the
90th percentile for FDR was less than 0.05. Results for the
four analyses were averaged for each fold change, and the
number of arrays required was plotted relative to the min-
imum detectable fold-change.
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